223 related articles for article (PubMed ID: 17363560)
1. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis.
Matthews CP; Birkholz AM; Baker AR; Perella CM; Beck GR; Young MR; Colburn NH
Cancer Res; 2007 Mar; 67(6):2430-8. PubMed ID: 17363560
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
3. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
4. Protection against human papillomavirus type 16-E7 oncogene-induced tumorigenesis by in vivo expression of dominant-negative c-jun.
Young MR; Farrell L; Lambert P; Awasthi P; Colburn NH
Mol Carcinog; 2002 Jun; 34(2):72-7. PubMed ID: 12112313
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion.
Young MR; Li JJ; Rincón M; Flavell RA; Sathyanarayana BK; Hunziker R; Colburn N
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9827-32. PubMed ID: 10449779
[TBL] [Abstract][Full Text] [Related]
6. A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion.
Thompson EJ; MacGowan J; Young MR; Colburn N; Bowden GT
Cancer Res; 2002 Jun; 62(11):3044-7. PubMed ID: 12036911
[TBL] [Abstract][Full Text] [Related]
7. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes.
Li JJ; Cao Y; Young MR; Colburn NH
Mol Carcinog; 2000 Nov; 29(3):159-69. PubMed ID: 11108661
[TBL] [Abstract][Full Text] [Related]
8. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.
Cooper S; Ranger-Moore J; Bowden TG
Mol Carcinog; 2005 Jun; 43(2):108-16. PubMed ID: 15791649
[TBL] [Abstract][Full Text] [Related]
10. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes.
Dong Z; Crawford HC; Lavrovsky V; Taub D; Watts R; Matrisian LM; Colburn NH
Mol Carcinog; 1997 Jul; 19(3):204-12. PubMed ID: 9254887
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
[TBL] [Abstract][Full Text] [Related]
12. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors.
Chiou YS; Sang S; Cheng KH; Ho CT; Wang YJ; Pan MH
Carcinogenesis; 2013 Jun; 34(6):1315-22. PubMed ID: 23385063
[TBL] [Abstract][Full Text] [Related]
13. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
Shrotriya S; Kundu JK; Na HK; Surh YJ
Cancer Res; 2010 Mar; 70(5):1932-40. PubMed ID: 20179211
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
Subbaramaiah K; Dannenberg AJ
Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
[TBL] [Abstract][Full Text] [Related]
15. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analysis by RNA-seq reveals AP-1 pathway as key regulator that green tea may rely on to inhibit lung tumorigenesis.
Pan J; Zhang Q; Xiong D; Vedell P; Yan Y; Jiang H; Cui P; Ding F; Tichelaar JW; Wang Y; Lubet RA; You M
Mol Carcinog; 2014 Jan; 53(1):19-29. PubMed ID: 24343902
[TBL] [Abstract][Full Text] [Related]
18. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
19. Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis.
Tsai ML; Lai CS; Chang YH; Chen WJ; Ho CT; Pan MH
Food Funct; 2012 Nov; 3(11):1185-94. PubMed ID: 22842666
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.
Zhao Y; Xue Y; Oberley TD; Kiningham KK; Lin SM; Yen HC; Majima H; Hines J; St Clair D
Cancer Res; 2001 Aug; 61(16):6082-8. PubMed ID: 11507057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
